Skip to main content
Premium Trial:

Request an Annual Quote

People in the News: Aug 23, 2011

Premium

Enzo Biochem has added four executives to lead its Enzo Life Sciences subsidiary. The new team will focus on pharmaceutical and clinical applications.

Bruce Taillon has been named head of global technology business development. He previously worked in Roche 454 Life Sciences, where he was responsible for world-wide business development efforts centered on the company's next-generation sequencing platform and its potential use in diagnostic assays.

John D’Errico will lead Enzo Life Sciences' commercial merchandising operations. D’Errico joins Enzo from VWR Scientific, where he managed that company's life sciences product portfolio. Before that, he worked at Harvard Biosciences, where he headed business development efforts for the firm's Genomic Solutions business, which was later sold to Digilab.

Kara Cannon has been appointed head of global marketing. She joins Enzo from Pall Corp., where she held executive positions in the areas of diagnostics, biotechnology, and biosciences.

Paul Munger has been tapped to lead Enzo Life Sciences' global manufacturing operations. He previously held an executive position at Pierce Chemical, now a division of Thermo Fisher Scientific, as well as a senior manufacturing management role at Transgenomic, where he was responsible for scaling up drug intermediate candidates. Most recently, Munger led the US-based manufacturing of regulated diagnostic kits for Idexx Labs.

The Scan

Unique Germline Variants Found Among Black Prostate Cancer Patients

Through an exome sequencing study appearing in JCO Precision Oncology, researchers have found unique pathogenic or likely pathogenic variants within a cohort of Black prostate cancer patients.

Analysis of Endogenous Parvoviral Elements Found Within Animal Genomes

Researchers at PLOS Biology have examined the coevolution of endogenous parvoviral elements and animal genomes to gain insight into using the viruses as gene therapy vectors.

Saliva Testing Can Reveal Mosaic CNVs Important in Intellectual Disability

An Australian team has compared the yield of chromosomal microarray testing of both blood and saliva samples for syndromic intellectual disability in the European Journal of Human Genetics.

Octopus Brain Complexity Linked to MicroRNA Expansions

Investigators saw microRNA gene expansions coinciding with complex brains when they analyzed certain cephalopod transcriptomes, as they report in Science Advances.